A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
Actuate Therapeutics Inc.
Rigel Pharmaceuticals
Deciphera Pharmaceuticals, LLC
Novartis
Bristol-Myers Squibb
Shenzhen BinDeBio Ltd.
INSYS Therapeutics Inc